MPM, No­var­tis lead a big launch round for Kazu­mi Sh­iosa­ki’s lat­est biotech start­up com­ing out of Har­vard

Kazu­mi Sh­iosa­ki has now wrapped her third launch round for a biotech start­up.

The MPM Cap­i­tal ex­ec­u­tive part­ner who helped found and ini­tial­ly ran Epizyme and Mi­to­bridge has been work­ing with a small team to help val­i­date the decade-long ef­fort at George Da­ley’s Har­vard lab to ex­plore a par­tic­u­lar path­way that ap­pears to be an im­por­tant play­er in can­cer pro­gres­sion. And now they have stitched to­geth­er an im­pres­sive $65 mil­lion round to take the next pre­clin­i­cal step to­ward mak­ing it a drug at 28-7 — as well as a show­piece for the plat­form work that’s be­ing planned around it.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER